49 Out of 52 Leprosy Diagnoses Occurred after COVID Vaccines.

There has been an increasing prevalence of leprosy after receiving the COVID-19 vaccination, with 49 out of the 52 people – 98 percent – transferred to the specialist Leprosy Clinic at the Hospital for Tropical Diseases in London (HTD) in 2021 being referred after the vaccine.
 
HTD undertook two case studies of people that matched the definition of an adverse reaction involving leprosy, whereby within 12 weeks of receiving the vaccine, someone developed the disease despite having no previous diagnoses or connections. One individual developed “borderline tuberculoid leprosy” a week after the second jab and the other within two months of a COVID-19 vaccine dose.